Skip to content

GCRI · 生物技术与生物安全

创新与实用技术

Technology relevant to health and biosecurity and food and agriculture: what it can do, the constraints it faces and its consequences for people and institutions.

01顺序

事情发生的顺序。

  1. 01草稿已引用来源,已附标签
  2. 02证据核查每个数值均可追溯
  3. 03独立审查已申报的利益冲突
  4. 04版本连同其局限一并发布
  5. 05更正新版本,绝不进行无声修改
02方法

Evaluate before adopting.

  1. 01

    Need

    Which problem does the technology address, and for whom?

  2. 02

    证据

    What has been demonstrated, under what conditions, and what remains untested?

  3. 03

    Constraints

    Cost, skills, infrastructure, data and governance requirements.

  4. 04

    Consequences

    Effects on safety, rights, equity and the environment.

03Technologies under assessment

What could change biosecurity practice, and what it still has to show.

技术What it could changeWhat remains to be shown
Governance tools for 两用研究 reviewConsistent oversightEvidence of effectiveness
Distributed countermeasure manufacturingFaster supplyQuality assurance
04Build and test

From idea to tested capability.

Promising work can be built in Foundry and tested under controlled conditions through 宇宙. No technology is described as proven before it has been tested and reviewed.

05来源

Where this page’s references lead.

阅读本页时所对照的机构和文件。状态和版本会变化;每个链接都指向发布机构。

06问题

问题与解答。

Does the platform endorse products?
No. It evaluates technologies and publishes what it finds, with limits. It does not endorse, certify or recommend products or vendors.
报告贡献

从本页贡献证据。

报告 is the Consortium’s quarterly publication. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work.

GCRI生物技术与生物安全指数级技术证据简报
生物技术与生物安全

带来一种方法、一个数据集或一个问题。

信息和咨询现已开放。每项咨询都会获得一个编号,并告知下一步;申请、付款、算力分配和注册只有在相应团队、条款和审查能力就绪时才会开放。